Louis Moore Bacon's GPAT Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 50,000 shares of GP-Act III Acquisition Corp. (GPAT) worth $543,500, representing 0.01% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 8 quarters.
Based on 13F filings, Louis Moore Bacon has maintained this position in GPAT for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q2 2026, reducing 150,000 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's GP-Act III Acquisition (GPAT) Holding Value Over Time
Track share changes against reported price movement
Quarterly GP-Act III Acquisition (GPAT) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -150,000 | Reduce 75.00% | 50,000 | $10.87 |
| Q3 2024 | +200,000 | New Buy | 200,000 | $10.08 |
Louis Moore Bacon's GP-Act III Acquisition Investment FAQs
Louis Moore Bacon first purchased GP-Act III Acquisition Corp. (GPAT) in Q3 2024, acquiring 200,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held GP-Act III Acquisition Corp. (GPAT) for 8 quarters since Q3 2024.
Louis Moore Bacon's largest addition to GP-Act III Acquisition Corp. (GPAT) was in Q3 2024, adding 200,000 shares worth $2.02 M.
According to the latest 13F filing for Q2 2026, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 50,000 shares of GP-Act III Acquisition Corp. (GPAT), valued at approximately $543,500.
As of the Q2 2026 filing, GP-Act III Acquisition Corp. (GPAT) represents approximately 0.01% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in GP-Act III Acquisition Corp. (GPAT) was 200,000 shares, as reported at the end of Q3 2024.